Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Clinical Pharmacology and Therapeutics
|
September 6, 2012
A perspective on efflux transport proteins in the liver
K Köck, K L R Brouwer
CPT: Pharmacometrics & Systems Pharmacology
|
March 7, 2014
Population pharmacokinetics of azithromycin in whole blood, peripheral blood mononuclear cells, and polymorphonuclear cells in healthy adults
M R Sampson, T P Dumitrescu, K L R Brouwer, et al.
Clinical Pharmacology and Therapeutics
|
July 29, 2014
Systems pharmacology modeling predicts delayed presentation and species differences in bile acid-mediated troglitazone hepatotoxicity
K Yang, J L Woodhead, P B Watkins, et al.
Antimicrobial Agents and Chemotherapy
|
May 1, 2013
Development of a population pharmacokinetic model to describe azithromycin whole-blood and plasma concentrations over time in healthy subjects
T Pene Dumitrescu, T Anic-Milic, K Oreskovic, et al.
Clinical Pharmacology and Therapeutics
|
January 20, 2007
In vitro-in vivo correlation of hepatobiliary drug clearance in humans
G Ghibellini, L S Vasist, E M Leslie, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
September 16, 2004
Comparison of the acute pharmacodynamic responses after single doses of ephedrine or sibutramine in healthy, overweight volunteers
A M Persky, C Ng, M H Song, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
July 27, 2013
Effect of Ritonavir on (99m)Technetium-Mebrofenin Disposition in Humans: A Semi-PBPK Modeling and In Vitro Approach to Predict Transporter-Mediated DDIs
N D Pfeifer, S L Goss, B Swift, et al.
Clinical Pharmacology and Therapeutics
|
April 17, 2013
In vitro methods to support transporter evaluation in drug discovery and development
K L R Brouwer, D Keppler, K A Hoffmaster, et al.
Clinical Pharmacology and Therapeutics
|
February 12, 2015
Altered morphine glucuronide and bile acid disposition in patients with nonalcoholic steatohepatitis
B C Ferslew, C K Johnston, E Tsakalozou, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
July 10, 2014
Mechanistic Modeling Reveals the Critical Knowledge Gaps in Bile Acid-Mediated DILI
J L Woodhead, K Yang, K L R Brouwer, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Clinical Pharmacology and Therapeutics
|
September 6, 2012
A perspective on efflux transport proteins in the liver
K Köck, K L R Brouwer
CPT: Pharmacometrics & Systems Pharmacology
|
March 7, 2014
Population pharmacokinetics of azithromycin in whole blood, peripheral blood mononuclear cells, and polymorphonuclear cells in healthy adults
M R Sampson, T P Dumitrescu, K L R Brouwer, et al.
Clinical Pharmacology and Therapeutics
|
July 29, 2014
Systems pharmacology modeling predicts delayed presentation and species differences in bile acid-mediated troglitazone hepatotoxicity
K Yang, J L Woodhead, P B Watkins, et al.
Antimicrobial Agents and Chemotherapy
|
May 1, 2013
Development of a population pharmacokinetic model to describe azithromycin whole-blood and plasma concentrations over time in healthy subjects
T Pene Dumitrescu, T Anic-Milic, K Oreskovic, et al.
Clinical Pharmacology and Therapeutics
|
January 20, 2007
In vitro-in vivo correlation of hepatobiliary drug clearance in humans
G Ghibellini, L S Vasist, E M Leslie, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
September 16, 2004
Comparison of the acute pharmacodynamic responses after single doses of ephedrine or sibutramine in healthy, overweight volunteers
A M Persky, C Ng, M H Song, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
July 27, 2013
Effect of Ritonavir on (99m)Technetium-Mebrofenin Disposition in Humans: A Semi-PBPK Modeling and In Vitro Approach to Predict Transporter-Mediated DDIs
N D Pfeifer, S L Goss, B Swift, et al.
Clinical Pharmacology and Therapeutics
|
April 17, 2013
In vitro methods to support transporter evaluation in drug discovery and development
K L R Brouwer, D Keppler, K A Hoffmaster, et al.
Clinical Pharmacology and Therapeutics
|
February 12, 2015
Altered morphine glucuronide and bile acid disposition in patients with nonalcoholic steatohepatitis
B C Ferslew, C K Johnston, E Tsakalozou, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
July 10, 2014
Mechanistic Modeling Reveals the Critical Knowledge Gaps in Bile Acid-Mediated DILI
J L Woodhead, K Yang, K L R Brouwer, et al.
Page
of 2